A common cold medicine has been deemed ineffective and will no longer be available for purchase. The Food and Drug Administration announced Wednesday its intention to remove oral phenylephrine, a ...

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "FDA Regulation for Over-the-Counter (OTC) Drug Products (Aug 22, 2025)" training has been added to ResearchAndMarkets.com's offering. This 90-minute ...

The U.S. Food and Drug Administration on Wednesday approved selling the leading version of naloxone without a prescription, setting the overdose-reversing drug on course to become the first opioid ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The Abbott Libre Rio was cleared for adults with type 2 ...

Ohio Sen. Jon Husted’s bipartisan drug bill has become law as President Donald Trump approved the appropriations package.

On 2, 2025, President Trump signed H.R. 5371, the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction ...

On Thursday, the FDA proposed removing oral phenylephrine from the list of approved active ingredients for over-the-counter (OTC) nasal decongestants, citing concerns over its effectiveness. After ...

The FDA finalized a rule stating that triclosan and 23 other active ingredients are not “generally recognized as safe and effective for use in over-the-counter healthcare antiseptic products.” The OTC ...

In the Continuing Resolution and Appropriations Package (H.R. 5371), enacted into law on 2, 2025, Congress included several new ...

Common oral medicines that have been used for decades as decongestants such as Sudafed, NyQuil and Benadryl may soon be cleared from shelves as the FDA has proposed to discontinue the sale of products ...

The US Food and Drug Administration (FDA) has announced new action to encourage companies to develop naloxone products for over-the-counter (OTC) use — or apply to switch certain products from ...